Extreme growth factor signalling can promote oestrogen receptor-alpha loss: therapeutic implications in breast cancer

Breast Cancer Res. 2004;6(4):162-3. doi: 10.1186/bcr904. Epub 2004 Jun 9.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology*
  • Cytoplasm / chemistry
  • Cytoplasm / enzymology
  • Enzyme Activation / physiology
  • Estrogen Receptor alpha
  • Growth Substances / metabolism*
  • MAP Kinase Kinase 2
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Mitogen-Activated Protein Kinases / metabolism
  • NF-kappa B / metabolism
  • Protein-Tyrosine Kinases / metabolism
  • Receptors, Estrogen / metabolism*
  • Signal Transduction / physiology*
  • Substrate Specificity

Substances

  • Estrogen Receptor alpha
  • Growth Substances
  • NF-kappa B
  • Receptors, Estrogen
  • Protein-Tyrosine Kinases
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 2
  • Mitogen-Activated Protein Kinase Kinases